Next Article in Journal
Simultaneous Quantification of Propylthiouracil and Its N-β-d Glucuronide by HPLC-MS/MS: Application to a Metabolic Study
Next Article in Special Issue
Ranolazine: An Old Drug with Emerging Potential; Lessons from Pre-Clinical and Clinical Investigations for Possible Repositioning
Previous Article in Journal
In Vitro Methods to Decipher the Structure of Viral RNA Genomes
Previous Article in Special Issue
Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
 
 
Review
Peer-Review Record

SapC–DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents

Pharmaceuticals 2021, 14(11), 1193; https://doi.org/10.3390/ph14111193
by Ahmet Kaynak 1,2, Harold W. Davis 1, Subrahmanya D. Vallabhapurapu 1, Koon Y. Pak 3, Brian D. Gray 3 and Xiaoyang Qi 1,2,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Pharmaceuticals 2021, 14(11), 1193; https://doi.org/10.3390/ph14111193
Submission received: 11 October 2021 / Revised: 16 November 2021 / Accepted: 17 November 2021 / Published: 20 November 2021
(This article belongs to the Collection Old Pharmaceuticals with New Applications)

Round 1

Reviewer 1 Report

The work described in the present manuscript is consistent with the scope of the journal. SapC-DOPS as a Novel Therapeutic and Diagnostic Agent for Glioblastoma Therapy and Detection: Alternative to Old Drugs and Agents. This review work is methodically carried out and scientifically correct. The authors have discussed the novel in vivo and clinical approaches of radio-nanomedicine for GBM treatment and detection. Overall it’s a very good article and I highly recommend it. There are minor issues that the authors can address to improve their manuscript before acceptance for publication.

The novelty of the manuscript must be highlighted in the introduction section

The authors can include a table related to a clinical trials for Therapeutic and Diagnostic Agent studied for Glioblastoma Therapy

All figures have low resolutions. Authors should use high-resolution images.

Author Response

See the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

The authors have written a review about GBM and GBM treatments in general. The authors have given a very general review of previous GBM treatments finishing with a very specific review of their own works regarding SapC-DOPS. While the review is well written and clear major revisions are needed. First, the abstract only disucsses the authors own works, yet the first 7 pages are a review in general of GBM treatmens used in the past. Secondly the review is written in a first person way "We did....... our group examined" A review should look at the literature overall and not just self-cite. Therefore, the review should be rewritten, both to include the background etc, in the first 7 pages and to remove all direct self-references. Even if no other group works on these systems, direct self promotion should not be permitted. Finally, the conclusions are very specific only talking about a small portion of the results discussed and no expert opinion or future needs/missing pieces of these systems is discussed.

Author Response

See the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

I thank the authors for making the requested adjustments

 

Back to TopTop